Virus News and Research

Latest Virus News and Research

Media outlets continue to publish expert opinion regarding H5N1 bird flu research

The PBS NewsHour blog "The Rundown" features excerpts from interviews with three experts discussing the recent debate over research conducted on the H5N1 bird flu virus.

1 Feb 2012

NanoViricides files FluCide pre-IND briefing document with the FDA

NanoViricides, Inc. announced today that it has submitted a pre-IND briefing document to the US FDA. This submission provides the required information for the Company's highly effective anti-influenza drug candidate, FluCide, in support of a pre-IND Meeting.

1 Feb 2012

Study finds no link between BDV and psychiatric illness

Over the past 30 years, numerous studies have linked Borna disease virus (BDV) with mental illnesses such as bipolar disorder, schizophrenia, anxiety disorder and dementia. Genetic fragments and antibodies to this RNA virus, which causes behavior disorders in a range of mammals and birds, have been found to be prevalent in psychiatric patients, but study results have been inconsistent. Now, the first blinded, case-control study to examine this issue finds no association between the virus and psychiatric illness.

1 Feb 2012

Clorox launches new H2O2 cleaner disinfectant wipes and spray

Clorox Professional Products Company, a division of The Clorox Company announced today the introduction of Clorox Healthcare(TM) Hydrogen Peroxide Cleaner Disinfectant Wipes and Spray, a new line of ready-to-use, one-step cleaner disinfectants engineered with a patented activated hydrogen peroxide (H2O2) formula.

31 Jan 2012

HSP40/70 linked to hepatitis C infection

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.

31 Jan 2012

Experts to discuss controversial studies on avian flu virus at live event

On February 2 from 6pm to 8pm, the Emerging Infectious Diseases & Microbiology Discussion Group of the New York Academy of Sciences presents Dual Use Research: H5N1 Influenza Virus and Beyond, a discussion between scientists, publishers, and legal experts that will explore the myriad issues surrounding the impending publication of these two studies and measures that will need to be undertaken to ensure the security of future such research.

31 Jan 2012

Alnylam receives U.S. patent allowance for LNP platform

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application number 12/813,448, covering the company's proprietary second generation lipid nanoparticle (LNP) platform, including the "MC3" lipid.

30 Jan 2012

Bird flu detected in Victoria spurs action

A bird flu outbreak has been detected at two Victorian farms and at least 10,000 ducks will have to be destroyed. The two farms are about 25km apart in an area north of Melbourne, but officials are keeping the exact location private.

30 Jan 2012

NSABB explanation of decision to recommend censoring of bird flu research expected soon

The NIH is expected on February 1 to release a statement explaining how the U.S. National Science Advisory Board for Biosecurity (NSABB) reached a decision late last year to recommend "that two scientific papers describing research that created strains of bird flu potentially transmissible in humans should be published only if key details are omitted," for fear "that terrorists or hostile nations could learn how to cause a pandemic," a New York Times editorial by Philip Boffey, Times science editorial writer, states.

30 Jan 2012

Mosquito and Vector Control Association of California hosts 2012 Annual Conference

The Mosquito and Vector Control Association of California (MVCAC) will host its 2012 Annual Conference at the Hyatt Regency San Francisco Airport in Burlingame, California. The top issues being addressed at the conference are a new Clean Water Act permit requirement that may result in mosquito control agencies being unable to provide the same level of protection from vector-borne diseases and the recent infestation of the Asian tiger mosquito in Southern California.

30 Jan 2012

Researchers study new strategies to treat patients with influenza

Influenza virus can rapidly evolve from one form to another, complicating the effectiveness of vaccines and anti-viral drugs used to treat it. By first understanding the complex host cell pathways that the flu uses for replication, University of Georgia researchers are finding new strategies for therapies and vaccines, according to a study published in the January issue of the Journal of the Federation of American Societies for Experimental Biology.

30 Jan 2012

HPV transmission via oral sex practices suggests research

A new study suggested that an estimated 7% of American teens and adults carry the human papillomavirus in their mouths. This may help health experts finally understand why rates of mouth and throat cancer have been climbing for nearly 25 years. The evidence additionally makes it clear that oral sex practices play a key role in transmission.

29 Jan 2012

Bird flu investigator says continuation of research remains 'urgent' despite moratorium

Research into transmissible bird flu strains remains "urgent" despite flu investigators' recent declaration of a "60-day moratorium on avian flu transmission because of the current controversy," Yoshihiro Kawaoka of Tokyo University and the University of Wisconsin-Madison, "a lead researcher on one of two recent studies showing how H5N1 can be transmitted through airborne droplets" among ferrets, writes in a commentary published Wednesday in the journal Nature, Reuters reports.

27 Jan 2012

Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award

Research to Prevent Blindness (RPB) has granted Massachusetts Eye and Ear Infirmary cornea specialist James Chodosh, M.D., M.P.H., a $150,000 Senior Scientific Investigator Award. RPB Senior Scientific Investigator Awards support nationally recognized scientists conducting eye research at medical institutions in the United States.

27 Jan 2012

Boehringer Ingelheim initiates two afatinib phase III trials in head and neck cancer

Boehringer Ingelheim announced today the initiation of two phase III clinical trials, LUX-Head & Neck 1 and LUX-Head & Neck 2. These trials evaluate afatinib in patients with metastatic and recurrent head and neck cancer, and in patients with locally advanced disease, respectively.

27 Jan 2012

Universal access to HIV treatment can be achieved

"Thirty years after AIDS made its deadly debut, a future without the disease is finally within reach," a Boston Globe editorial states, adding, "But just as science is on the verge of winning the battle, financial resources and political will are flagging."

25 Jan 2012

OraQuick HIV1/2 test as accurate as traditional blood test

A saliva test used to diagnose the human immunodeficiency virus (HIV), is comparable in accuracy to the traditional blood test, according to a new study led by the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University.

25 Jan 2012

Genoscience, BioLineRx to develop and commercialize BL-8020 for HCV

BioLineRx, a biopharmaceutical development company, announced today it has signed a worldwide, exclusive license agreement with Genoscience, a French company focused on viral disease therapeutics, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C.

24 Jan 2012

Gilead commences GS-7340 Phase 2 trial in HIV

Gilead Sciences, Inc. today announced the initiation of a Phase 2 clinical trial evaluating GS-7340 for the treatment of HIV-1 infection in treatment-naïve adults. GS-7340 is a novel prodrug of tenofovir, the active agent in Viread.

24 Jan 2012

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

Johnson & Johnson today announced sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth quarter of 2010. Operational sales increased 4.0% and the negative impact of currency was 0.1%.

24 Jan 2012

Virus News and Research

Latest Virus News and Research

Media outlets continue to publish expert opinion regarding H5N1 bird flu research

NanoViricides files FluCide pre-IND briefing document with the FDA

Study finds no link between BDV and psychiatric illness

Clorox launches new H2O2 cleaner disinfectant wipes and spray

HSP40/70 linked to hepatitis C infection

Experts to discuss controversial studies on avian flu virus at live event

Alnylam receives U.S. patent allowance for LNP platform

Bird flu detected in Victoria spurs action

NSABB explanation of decision to recommend censoring of bird flu research expected soon

Mosquito and Vector Control Association of California hosts 2012 Annual Conference

Researchers study new strategies to treat patients with influenza

HPV transmission via oral sex practices suggests research

Bird flu investigator says continuation of research remains 'urgent' despite moratorium

Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award

Boehringer Ingelheim initiates two afatinib phase III trials in head and neck cancer

Universal access to HIV treatment can be achieved

OraQuick HIV1/2 test as accurate as traditional blood test

Genoscience, BioLineRx to develop and commercialize BL-8020 for HCV

Gilead commences GS-7340 Phase 2 trial in HIV

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in